Full Text:   <1491>

CLC number: R9

On-line Access: 

Received: 2005-06-21

Revision Accepted: 2005-07-17

Crosschecked: 0000-00-00

Cited: 12

Clicked: 4120

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
1. Reference List
Open peer comments

Journal of Zhejiang University SCIENCE B 2005 Vol.6 No.9 P.885~891


Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients

Author(s):  LU Xiao-yang, HUANG Hong-feng, SHENG-TU Jian-zhong, LIU Jian

Affiliation(s):  Department of Clinical Pharmacology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China

Corresponding email(s):   lxy00711@yahoo.com.cn

Key Words:  Mycophenolate mofetil, Mycophenolic acid, Pharmacokinetics, Kidney transplant

LU Xiao-yang, HUANG Hong-feng, SHENG-TU Jian-zhong, LIU Jian. Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients[J]. Journal of Zhejiang University Science B, 2005, 6(9): 885~891.

@article{title="Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients",
author="LU Xiao-yang, HUANG Hong-feng, SHENG-TU Jian-zhong, LIU Jian",
journal="Journal of Zhejiang University Science B",
publisher="Zhejiang University Press & Springer",

%0 Journal Article
%T Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients
%A LU Xiao-yang
%A HUANG Hong-feng
%A SHENG-TU Jian-zhong
%A LIU Jian
%J Journal of Zhejiang University SCIENCE B
%V 6
%N 9
%P 885~891
%@ 1673-1581
%D 2005
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.2005.B0885

T1 - Pharmacokinetics of mycophenolic acid in Chinese kidney transplant patients
A1 - LU Xiao-yang
A1 - HUANG Hong-feng
A1 - SHENG-TU Jian-zhong
A1 - LIU Jian
J0 - Journal of Zhejiang University Science B
VL - 6
IS - 9
SP - 885
EP - 891
%@ 1673-1581
Y1 - 2005
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.2005.B0885

To assess the influence of cyclosporin A (CsA) and tacrolimus (FK506) on mycophenolic acid (MPA) and correlation analysis of the pharmacokinetic parameters and patient characteristics, clinical outcome in Chinese kidney transplant recipients, the pharmacokinetics of 1000 mg mycophenolate mofetil (MMF) twice daily was measured by high-performance liquid chromatography (HPLC). PKS (Pharmaceutical Kinetics Software) 1.0.2 software package was used for the calculation of pharmacokinetic parameters. The mean Cmax, tmax, and AUC(0−12)were (21.88±10.52) µg/ml, (1.20±0.95) h, and (52.546±13.215) µg·h/ml, respectively. The level of AUC(0−12) in the FK506 group was significantly higher than that in the CsA group. MPA appeared not to be affected by renal function. MPA AUC(0−12) showed statistically significant difference according to the patient’s gender.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article


[1] Bullingham, R.E., Nicholls, A., Hale, M., 1996a. Pharmacokinetics of mycophenolate mofetil (RS61443): A short review. Transplant. Proc., 28(2):925-929.

[2] Bullingham, R.E., Monroe, S., Nicholls, A., Hale, M., 1996b. Pharmacokinetics and bioavailability of mycophenolate mofetil in healthy subjects after single-dose oral and intravenous administration. J. Clin. Pharmacol., 36(4):315-324.

[3] Bullingham, R.E., Nicholls, A.J., Kamm, B.R., 1998. Pharmacokinetics of mycophenolate mofetil. Clin. Pharmacokinet., 34(6):429-455.

[4] Cho, E.K., Han, D.J., Kim, S.C., Burckart, G.J., Venkataramanan, R., Oh, J.M., 2004. Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patients. J. Clin. Pharmacol., 44(7):743-750.

[5] European Mycophenolate Mofetil Cooperative Study Group, 1995. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet., 345(8961):1321-1325.

[6] Filler, G., Zimmering, M., Mai, I., 2000. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression. Pediatr. Nephrol., 14(2):100-104.

[7] Gregoor, P.J., de Sevaux, R.G., Hene, R.J., Hesse, C.J., Hilbrands, L.B., Vos, P., van Gelder, T., Hoitsma, A.J., Weimar, W., 1999. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients. Transplantation, 68(10):1603-1606.

[8] Johnson, A.G., Rigby, R.J., Taylor, P.J., Jones, C.E., Allen, J., Franzen, K., Falk, M.C., Nicol, D., 1999. The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients. Clin. Pharmacol. Ther., 66(5):492-500.

[9] Kuriata-kordek, M., Boratynska, M., Falkiewicz, K., Porazko, T., Urbaniak, J., Wozniak, M., Patrzalek, D., Szyber, P., Klinger, M., 2003. The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics. Transplant. Proc., 35(6):2369-2371.

[10] Lee, H.J., Pawlak, K., Nguyen, B.T., Robinsm, R.K., Sadee, W., 1985. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studies in mouse lymphoma cell culture. Cancer Res., 45:5512-5520.

[11] Matsuzawa, Y., Nakase, T., 1984. Metabolic fate of ethyl O-[N-(p-carboxyphenyl)-carbamoyl] mycophenolate (CAM), a new antitumor agent, in experimental animals. J. Pharmacobiodyn., 7(10):776-783.

[12] Pescovitz, M.D., Guasch, A., Gaston, R., Rajagopalan, P., Tomlanovich, S., Weinstein, S., Bumgardner, G.L., Melton, L., Ducray, P.S., Banken, L., et al., 2003. Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipients. Am. J. Transplant., 3(12):1581-1586.

[13] Rasom, J.T., 1995. Mechanism of action of mycophenolate mofetil. Ther. Drug. Monit., 17(6):681-684.

[14] Shaw, L.M., Sollinger, H.W., Halloran, P., Morris, R.E., Yatscoff, R.W., Ransom, J., Tsina, I, Keown, P., Holt, D.W., Lieberman, R., 1995. Mycophenolate mofetil: A report of the consensus panel. Ther. Drug. Monit., 17(6):690-699.

[15] Shaw, L.M., Nicholl, A., Hale, M., Armstrong, V.W., Oellerich, M., Yatscoff, R., Morris, R.E., Holt, D.W., Venkataramanan, R., Haley, J., et al., 1998. Therapeutic monitoring of mycophenolic acid: A consensus panel report. Clin. Biochem., 31(5):317-322.

[16] Shaw, L.M., Kaplan, B., DeNofrio, D., Korecka, M., Brayman, K.L., 2000. Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther. Drug. Monit., 22(1):14-19.

[17] Shaw, L.M., Pawinski, T., Korecka, M., Nawrocki, A., 2002. Monitoring of mycophenolic acid in clinical transplantation. Ther. Drug. Monit., 24(1):68-73.

[18] Takahashi, K., Ochiai, T., Uchida, K., Yasumara, T., Ishibashi, M., Suzuki, S., Otsubo, O., Isono, K., Takagi, H., Oka, T., 1995. Pilot study of mycophenolate mofetil (RS-61443) in the prevention of acute rejection following renal transplantation in Japanese patients. RS-61443 Investigation Committee−Japan. Transplant. Proc., 27(1):1421-1424.

[19] Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group, 1996. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation, 61(7):1029-1037.

[20] Young, C.J., Sollinger, H.W., 1994. RS-61443: A new immunosuppressive agent. Transplant. Proc., 26(6):3144-3146.

[21] Zucker, K., Rosen, A., Tsaroucha, A., de Faria, L., Roth, D., Ciancio, G., Esquenazi, V., Burke, G., Tzakis, A., Miller, J., 1997. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mucophenolate mofetil in combination therapy, an analogous in vitro findings. Transpl. Immunol., 5(3):225-232.

[22] Zucker, K., Tsaroucha, A., Olsen, L., Esquenazi, V., Tzakis, A., Miller, J., 1999. Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation. Ther. Drug. Monit., 21(1):35-43.

Open peer comments: Debate/Discuss/Question/Opinion



2010-08-31 21:46:50


Please provide your name, email address and a comment

Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - Journal of Zhejiang University-SCIENCE